Gazyva 1,000 MG/40 ML vial 40ML

Ended Awarded Last action

Contract number
SPE2DR26FRC6B
Awardee
Awarding agency
Obligated
$10,326

Award facts

Contract value 100% obligated
$10,325.94 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $10,325.94 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for Gazyva (obinutuzumab) 1,000 mg/40 ml vial pharmaceutical supply.

Place of performance is Conshohocken, PA. Ultimate completion date is May 18, 2026. The order is firm fixed-price with no set-aside. The source does not identify the parent IDC vehicle name explicitly; however, Amerisourcebergen Drug Corp holds position on multiple DLA Troop Support Medical SPE2DX-series indefinite delivery contracts supporting pharmaceutical prime vendor programs for Defense Health Agency and military medical facilities globally.

Quick answers

Who was awarded contract SPE2DR26FRC6B?

SPE2DR26FRC6B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 27, 2026.

How much is contract SPE2DR26FRC6B worth?

The government has obligated $10,326 on SPE2DR26FRC6B.

Is contract SPE2DR26FRC6B an order under another contract?

Yes. SPE2DR26FRC6B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.

Was contract SPE2DR26FRC6B competed?

The extent of competition for SPE2DR26FRC6B was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award